financetom
Business
financetom
/
Business
/
JELD-WEN Holding's Q3 Adjusted Earnings, Revenue Decline; Full-Year Revenue Outlook Lowered
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
JELD-WEN Holding's Q3 Adjusted Earnings, Revenue Decline; Full-Year Revenue Outlook Lowered
Nov 5, 2024 3:12 AM

05:34 AM EST, 11/05/2024 (MT Newswires) -- JELD-WEN Holding ( JELD ) reported Q3 adjusted earnings Monday of $0.32 per share, down from $0.53 a year earlier.

Analysts polled by Capital IQ expected $0.40.

Revenue for the quarter ended Sept. 28 was $934.7 million, compared with $1.08 billion a year earlier.

Analysts polled by Capital IQ expected $990.6 million.

The company lowered its full-year revenue guidance to between $3.7 billion and $3.75 billion, from the previous range of $3.9 billion to $4.1 billion. Analysts polled by Capital IQ expect $3.85 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mangoceuticals Develops Oral GLP-1s: Stock Soars
Mangoceuticals Develops Oral GLP-1s: Stock Soars
May 21, 2024
Mangoceuticals, Inc. ( MGRX ) shares are trading higher Tuesday after the company announced the development of oral formulations of Semaglutide and Tirzepatide. The Details: Mangoceuticals ( MGRX ) announced the development of proprietary oral formulations of Semaglutide (“Slim”) and Tirzepatide (“Trim”) to aid in weight management. The company plans to have the products available for customers in the beginning...
Sona Nanotech Appoints Chief Medical Officer, Files Provisional Conjugation Patent
Sona Nanotech Appoints Chief Medical Officer, Files Provisional Conjugation Patent
May 21, 2024
10:49 AM EDT, 05/21/2024 (MT Newswires) -- Sona Nanotech ( SNANF ) said Tuesday it has appointed Dr. Carman Giacomantonio M.D. as Chief Medical Officer. A practicing surgical oncologist at the QEII Health Sciences Centre and a Professor of Surgery at Dalhousie University, Dr. Giacomantonio leads a productive translational research group at the university and has successfully initiated two clinical...
Birchcliff Energy Gets $7 Price Target from RBC Capital Markets
Birchcliff Energy Gets $7 Price Target from RBC Capital Markets
May 21, 2024
10:55 AM EDT, 05/21/2024 (MT Newswires) -- Birchcliff Energy ( BIREF ) received a $7 price target as the company is expected to remain flexible amid low natural gas prices, RBC Capital Markets said Tuesday. According to RBC, Birchcliff's first-quarter volumes and adjusted funds from operations beat Street estimates, while its 2024 guidance remained relatively unchanged. RBC said Birchcliff is...
Toyota mulls over $500 mln investment into Texas plant
Toyota mulls over $500 mln investment into Texas plant
May 21, 2024
May 21 (Reuters) - Toyota Motor's ( TM ) North America arm is seeking tax relief for a potential project totaling $531.7 million in investments at its Texas facility, which manufactures the Toyota Tundra pickup truck and Sequoia SUV, the company said on Tuesday. Major automakers are now refocusing their efforts and investments on hybrid and gasoline-powered vehicles with better...
Copyright 2023-2026 - www.financetom.com All Rights Reserved